Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | ubiquitin specific peptidase 1 | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | GPCR family 2 | 0.0047 | 0.2213 | 0.7957 |
Brugia malayi | hypothetical protein | 0.002 | 0.0237 | 0.0237 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.2213 | 0.2213 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0047 | 0.2213 | 0.7957 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0123 | 0.7656 | 0.7656 |
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.2213 | 0.3607 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.1009 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0047 | 0.2213 | 0.7957 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2782 | 0.4533 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.2782 | 0.2782 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0149 | 0.9518 | 0.9518 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0102 | 0.6137 | 0.6137 |
Brugia malayi | MH2 domain containing protein | 0.0123 | 0.7656 | 0.7656 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 0.9518 | 0.9518 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.1009 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.6137 | 0.6137 |
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.2213 | 0.3607 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.2782 | 0.2782 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.2782 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0047 | 0.2213 | 0.2213 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2782 | 0.4533 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0123 | 0.7656 | 0.7656 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.1009 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2782 | 0.4533 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0047 | 0.2213 | 0.2213 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.1009 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.2213 | 0.3607 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.1009 | 0.1009 |
Echinococcus multilocularis | GPCR, family 2 | 0.0047 | 0.2213 | 0.7957 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0047 | 0.2213 | 0.7957 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0047 | 0.2213 | 0.7957 |
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.2213 | 0.3607 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.1009 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0047 | 0.2213 | 0.2213 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.1009 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.2782 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.2782 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.1009 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.1009 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0149 | 0.9518 | 0.9518 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.2782 | 1 |
Brugia malayi | hypothetical protein | 0.003 | 0.1009 | 0.1009 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0149 | 0.9518 | 0.9518 |
Schistosoma mansoni | hypothetical protein | 0.0102 | 0.6137 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.0891 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.8913 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.6234 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.0999 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.